Generation Bio Co at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone, and thank you for joining us at the second day of the Needham and Company Healthcare Conference. My name is Gil Blum, and I am a senior biotech analyst here at Needham & Co., and I cover both the gene therapy and immuno-oncology subsectors. It is my pleasure to have with me today, Geoff McDonough, the CEO of Generation Bio. (Conference Instructions)
Questions & Answers
Without further ado, we can get started. Some people don't know the Generation Bio story too well. Maybe as an introduction, just talk a little bit about the technology. And what is the problem that you're really trying to solve?
Thanks, Gil, and thanks for the invitation to be here. It's always fun to chat and [it'd] be a great half an hour together.
Generation Bio is about redosable DNA therapeutics at scale and let's just parse what that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |